Research graph
References from Do investigators show selection biases when enrolling patients in phase I oncology registration trials?. Local targets link to admitted publications; unresolved targets remain external evidence.
Risks and benefits of phase 1 oncology trials, 1991 through 2002
10.1056/nejmsa042220 · 2005 · External reference
Responses and toxic deaths in phase I clinical trials
10.1093/oxfordjournals.annonc.a057716 · 1990 · External reference
Therapeutic response in phase I trials of antineoplastic agents
1986 · External reference
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials
10.1023/a:1008368319526 · 2000 · External reference
Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs. new noncytotoxic agents
10.1038/sj.bjc.6601218 · 2003 · External reference
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials
10.1001/jama.292.17.2130 · 2004 · External reference
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience
10.1038/sj.bjc.6604218 · 2008 · External reference
Pharmaceutical research and development
2010 · External reference
The advisory process for anticancer drug regulation: a global perspective
10.1093/annonc/mdj099 · 2006 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
2003 · External reference
Annual Report on Health
2004 · External reference
Unresolved reference
External reference
Prognostic factors for survival in patients treated in phase I clinical trials
10.1002/1097-0142(19941001)74:7<1965::aid-cncr2820740723>3.0.co;2-1 · 1994 · External reference
Participants in phase 1 oncology research trials: are they vulnerable?
10.1001/archinternmed.2007.6 · 2008 · External reference
Prognostic factors among cancer patients with good performance status screened for phase I trials
10.1007/s10637-007-9088-x · 2008 · External reference
Cancer statistics
10.3322/canjclin.50.1.7 · 2000 · External reference
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review
10.1002/cncr.23157 · 2008 · External reference
Systemic review of barriers to the recruitment of older patients with cancer onto clinical trials
10.1200/jco.2005.00.141 · 2005 · External reference
Enrollment of elderly patients in clinical trial for cancer drug registration: a 7-year experience by the US Food and Drug Administration
10.1200/jco.2004.02.175 · 2004 · External reference
Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD
10.7326/0003-4819-104-6-757 · 1986 · External reference
A new model for predicting infectious complications during fludarabine-based combination chemotherapy among patients with indolent lymphoid malignancies
10.1002/cncr.20615 · 2004 · External reference
A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index
10.1111/j.1365-2141.2005.05508.x · 2005 · External reference
Unresolved reference
2009 · External reference
